WTMF:NYE-WisdomTree Managed Futures Strategy (USD)

ETF | Managed Futures |

Last Closing

USD 35.77

Change

+0.03 (+0.08)%

Market Cap

USD 0.21B

Volume

5.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund normally invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in managed futures. It is an actively managed exchange traded fund (ETF) that seeks to achieve positive total returns in rising or falling markets that are not directly correlated to broad market equity or fixed income returns. It is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Managed Futures

Symbol Name Price(Change) Market Cap
DBMF iMGP DBi Managed Futures Strat..

-0.13 (-0.46%)

USD 0.96B
FMF First Trust Managed Futures St..

-0.36 (-0.75%)

USD 0.20B

ETFs Containing WTMF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Managed Futures) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.00% 33% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.00% 33% F 25% F
Trailing 12 Months  
Capital Gain 1.17% 100% F 24% F
Dividend Return 4.70% 100% F 63% D
Total Return 5.87% 100% F 27% F
Trailing 5 Years  
Capital Gain -7.21% 33% F 36% F
Dividend Return 22.61% 100% F 75% C
Total Return 15.40% 100% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 0.14% 33% F 38% F
Dividend Return 5.77% 67% D+ 50% F
Total Return 5.63% 100% F 84% B
Risk Return Profile  
Volatility (Standard Deviation) 8.06% 67% D+ 82% B
Risk Adjusted Return 71.62% 67% D+ 86% B+
Market Capitalization 0.21B 67% D+ 36% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike